PATENT CLAIM ANALYSIS

Application Number: 15882832
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "027000"]

Abstract:
The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.

Claim (Index 22):
The method of  claim 20 , wherein the dosage form is selected from the group consisting of powder, capsule, lozenge, troche, tablet, liquid, or caplet.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12609120', '14681817', '13697794', '14434328', '15210565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948385122769314
- 35 USC 102 Novelty (BERT): 0.6676935586108217
- Combined Prediction Score: 0.7821240169103204
- Mean Citation Score: 474.31288400000005
- Max Citation Score: 828.4388
- Similarity Product: 614.9751841019392

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test